CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 31 enrolled
Drug / intervention
Normal nicotine content cigarettes (NNC, Baseline) +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03311646
NCT03311646N/ACompleted

Impact of Exclusive Use of Low Nicotine Cigarettes on Compensatory Smoking

Medical University of South Carolina·interventional·Posted Oct 17, 2017·Updated Jan 28, 2020

In Brief

A clinical study evaluating Normal nicotine content cigarettes (NNC, Baseline) and Very low nicotine content (VLNC) for Smoking. Completed, enrolled 31 participants across 1 site.

Detailed Summary

Smoking is the leading cause of preventable death in the United States. An FDA-mandated reduction in the nicotine content of cigarettes might reduce the health burden of tobacco by reducing the prevalence of smoking. The proposed project will test the impact of nicotine reduction on smoking behavior and smoke exposure in a setting where participants are restricted from using their usual brand cigarettes.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSmoking
CountriesUnited States

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedOct 17, 2017
Enrollment StartApr 15, 2018
Primary CompletionNov 15, 2018
Study CompletionDec 1, 2018
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 8.7 years ago

Interventions

Normal nicotine content cigarettes (NNC, Baseline)other

Participants will exclusively smoke research cigarettes that have a normal nicotine content for five days/four nights while staying in a hotel.

Very low nicotine content (VLNC)other

Participants will exclusively smoke research cigarettes that have a very low nicotine content for five days/four nights while staying in a hotel.